_id
690dab1fccc777a4e85d0905
Ticker
AGL
Name
agilon health Inc
Exchange
NYSE
Address
440 Polaris Parkway, Westerville, OH, United States, 43082
Country
USA
Sector
Healthcare
Industry
Medical Care Facilities
Currency
USD
Website
https://www.agilonhealth.com
Description
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Last Close
0.6941
Volume
6907347
Current Price
0.65
Change
-6.353551361475295
Last Updated
2025-11-28T11:57:19.035Z
Image
-
Ipo Date
2021-04-15T00:00:00.000Z
Market Cap
275406560
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9343400000000001
Sentiment Sources
35
Rating
3.3
Target Price
1.0083
Strong Buy
4
Buy
0
Hold
14
Sell
2
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1435321000
Cost Of Revenue
1510397000
Gross Profit
-75076000
Operating Expenses
52106000
Operating Income
-127182000
Interest Expense
1838000
Pretax Income
-110538000
Net Income
-110207000
Eps
-0.26590182524459244
Dividends Per Share
-
Shares Outstanding
414581604
Income Tax Expense
-331000
EBITDA
-101270000
Operating Margin
-8.860875023775169
Total Other Income Expense Net
16644000
Cash
171684000
Short Term Investments
139170000
Receivables
947157000
Inventories
-
Total Current Assets
1338028000
Property Plant Equipment
30084000
Total Assets
1596245000
Payables
145517000
Short Term Debt
34966000
Long Term Debt
-
Total Liabilities
1290168000
Equity
306077000
Depreciation
7430000
Change In Working Capital
92722000
Cash From Operations
-18154000
Capital Expenditures
3175000
Cash From Investing
18658000
Cash From Financing
-236000
Net Change In Cash
268000
PE
-
PB
0.8801780270977565
ROE
-36.00629906853504
ROA
-6.904140655099937
FCF
-21329000
Fcf Percent
-0.014860090530271626
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
3.5
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1435321000
Quarters > 0 > income Statement > cost Of Revenue
1510397000
Quarters > 0 > income Statement > gross Profit
-75076000
Quarters > 0 > income Statement > operating Expenses
52106000
Quarters > 0 > income Statement > operating Income
-127182000
Quarters > 0 > income Statement > interest Expense
1838000
Quarters > 0 > income Statement > pretax Income
-110538000
Quarters > 0 > income Statement > net Income
-110207000
Quarters > 0 > income Statement > eps
-0.26590182524459244
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
414465000
Quarters > 0 > income Statement > income Tax Expense
-331000
Quarters > 0 > income Statement > EBITDA
-101270000
Quarters > 0 > income Statement > operating Margin
-8.860875023775169
Quarters > 0 > income Statement > total Other Income Expense Net
16644000
Quarters > 0 > balance Sheet > cash
171684000
Quarters > 0 > balance Sheet > short Term Investments
139170000
Quarters > 0 > balance Sheet > receivables
947157000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1338028000
Quarters > 0 > balance Sheet > property Plant Equipment
30084000
Quarters > 0 > balance Sheet > total Assets
1596245000
Quarters > 0 > balance Sheet > payables
145517000
Quarters > 0 > balance Sheet > short Term Debt
34966000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1290168000
Quarters > 0 > balance Sheet > equity
306077000
Quarters > 0 > cash Flow > net Income
-110207000
Quarters > 0 > cash Flow > depreciation
7430000
Quarters > 0 > cash Flow > change In Working Capital
92722000
Quarters > 0 > cash Flow > cash From Operations
-18154000
Quarters > 0 > cash Flow > capital Expenditures
3175000
Quarters > 0 > cash Flow > cash From Investing
18658000
Quarters > 0 > cash Flow > cash From Financing
-236000
Quarters > 0 > cash Flow > net Change In Cash
268000
Quarters > 0 > ratios > PE
-0.26590182524459244
Quarters > 0 > ratios > PB
0.8801780270977565
Quarters > 0 > ratios > ROE
-36.00629906853504
Quarters > 0 > ratios > ROA
-6.904140655099937
Quarters > 0 > ratios > FCF
-21329000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.014860090530271626
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1394982000
Quarters > 1 > income Statement > cost Of Revenue
1447409000
Quarters > 1 > income Statement > gross Profit
-52427000
Quarters > 1 > income Statement > operating Expenses
63600000
Quarters > 1 > income Statement > operating Income
-116027000
Quarters > 1 > income Statement > interest Expense
1572000
Quarters > 1 > income Statement > pretax Income
-104308000
Quarters > 1 > income Statement > net Income
-104370000
Quarters > 1 > income Statement > eps
-0.25220135512618524
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
413836000
Quarters > 1 > income Statement > income Tax Expense
62000
Quarters > 1 > income Statement > EBITDA
-95417000
Quarters > 1 > income Statement > operating Margin
-8.317454992250797
Quarters > 1 > income Statement > total Other Income Expense Net
11719000
Quarters > 1 > balance Sheet > cash
171416000
Quarters > 1 > balance Sheet > short Term Investments
155585000
Quarters > 1 > balance Sheet > receivables
1047164000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1452660000
Quarters > 1 > balance Sheet > property Plant Equipment
36238000
Quarters > 1 > balance Sheet > total Assets
1712895000
Quarters > 1 > balance Sheet > payables
1214143000
Quarters > 1 > balance Sheet > short Term Debt
34945000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
1303966000
Quarters > 1 > balance Sheet > equity
408929000
Quarters > 1 > cash Flow > net Income
-104370000
Quarters > 1 > cash Flow > depreciation
7319000
Quarters > 1 > cash Flow > change In Working Capital
52875000
Quarters > 1 > cash Flow > cash From Operations
-35085000
Quarters > 1 > cash Flow > capital Expenditures
3250000
Quarters > 1 > cash Flow > cash From Investing
70458000
Quarters > 1 > cash Flow > cash From Financing
-2580000
Quarters > 1 > cash Flow > net Change In Cash
32793000
Quarters > 1 > ratios > PE
-0.25220135512618524
Quarters > 1 > ratios > PB
0.6577997647513383
Quarters > 1 > ratios > ROE
-25.522768011072827
Quarters > 1 > ratios > ROA
-6.093193102904731
Quarters > 1 > ratios > FCF
-38335000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.027480641327271606
Quarters > 1 > health Score
16
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1532782000
Quarters > 2 > income Statement > cost Of Revenue
1482060000
Quarters > 2 > income Statement > gross Profit
50722000
Quarters > 2 > income Statement > operating Expenses
72832000
Quarters > 2 > income Statement > operating Income
-22110000
Quarters > 2 > income Statement > interest Expense
1515000
Quarters > 2 > income Statement > pretax Income
-1692000
Quarters > 2 > income Statement > net Income
12112000
Quarters > 2 > income Statement > eps
0.029331421818393166
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
412936000
Quarters > 2 > income Statement > income Tax Expense
196000
Quarters > 2 > income Statement > EBITDA
6699000
Quarters > 2 > income Statement > operating Margin
-1.4424751856428377
Quarters > 2 > income Statement > total Other Income Expense Net
20418000
Quarters > 2 > balance Sheet > cash
138623000
Quarters > 2 > balance Sheet > short Term Investments
230143000
Quarters > 2 > balance Sheet > receivables
1239603000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1650722000
Quarters > 2 > balance Sheet > property Plant Equipment
37831000
Quarters > 2 > balance Sheet > total Assets
1932861000
Quarters > 2 > balance Sheet > payables
1339777000
Quarters > 2 > balance Sheet > short Term Debt
34924000
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
1432607000
Quarters > 2 > balance Sheet > equity
500254000
Quarters > 2 > cash Flow > net Income
12112000
Quarters > 2 > cash Flow > depreciation
6876000
Quarters > 2 > cash Flow > change In Working Capital
-38794000
Quarters > 2 > cash Flow > cash From Operations
-31987000
Quarters > 2 > cash Flow > capital Expenditures
10883000
Quarters > 2 > cash Flow > cash From Investing
-23089000
Quarters > 2 > cash Flow > cash From Financing
-161000
Quarters > 2 > cash Flow > net Change In Cash
-55237000
Quarters > 2 > ratios > PE
0.029331421818393166
Quarters > 2 > ratios > PB
0.5365442355283516
Quarters > 2 > ratios > ROE
2.4211700456168264
Quarters > 2 > ratios > ROA
0.6266358522418322
Quarters > 2 > ratios > FCF
-42870000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.027968752242654205
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1522486000
Quarters > 3 > income Statement > cost Of Revenue
1560741000
Quarters > 3 > income Statement > gross Profit
-38255000
Quarters > 3 > income Statement > operating Expenses
69845000
Quarters > 3 > income Statement > operating Income
-108100000
Quarters > 3 > income Statement > interest Expense
1574000
Quarters > 3 > income Statement > pretax Income
-104673000
Quarters > 3 > income Statement > net Income
-105790000
Quarters > 3 > income Statement > eps
-0.25674442535263226
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
412044000
Quarters > 3 > income Statement > income Tax Expense
1757000
Quarters > 3 > income Statement > EBITDA
-96605000
Quarters > 3 > income Statement > operating Margin
-7.100229493079083
Quarters > 3 > income Statement > total Other Income Expense Net
3427000
Quarters > 3 > balance Sheet > cash
193860000
Quarters > 3 > balance Sheet > short Term Investments
211737000
Quarters > 3 > balance Sheet > receivables
1017040000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1457774000
Quarters > 3 > balance Sheet > property Plant Equipment
36952000
Quarters > 3 > balance Sheet > total Assets
1733983000
Quarters > 3 > balance Sheet > payables
1149546000
Quarters > 3 > balance Sheet > short Term Debt
2460000
Quarters > 3 > balance Sheet > long Term Debt
34904000
Quarters > 3 > balance Sheet > total Liabilities
1263031000
Quarters > 3 > balance Sheet > equity
470952000
Quarters > 3 > cash Flow > net Income
-105790000
Quarters > 3 > cash Flow > depreciation
6494000
Quarters > 3 > cash Flow > change In Working Capital
105765000
Quarters > 3 > cash Flow > cash From Operations
16419000
Quarters > 3 > cash Flow > capital Expenditures
12423000
Quarters > 3 > cash Flow > cash From Investing
23673000
Quarters > 3 > cash Flow > cash From Financing
-22000
Quarters > 3 > cash Flow > net Change In Cash
40070000
Quarters > 3 > ratios > PE
-0.25674442535263226
Quarters > 3 > ratios > PB
0.5686961728583805
Quarters > 3 > ratios > ROE
-22.463011092425557
Quarters > 3 > ratios > ROA
-6.100982535584259
Quarters > 3 > ratios > FCF
3996000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.0026246546766275683
Quarters > 3 > health Score
19
Valuation > metrics > PE
-0.26590182524459244
Valuation > metrics > PB
0.8801780270977565
Valuation > final Score
70
Valuation > verdict
12.0% Undervalued
Profitability > metrics > ROE
-36.00629906853504
Profitability > metrics > ROA
-8.236524198297793
Profitability > metrics > Net Margin
-0.07678212748228445
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
4.215174612924199
Risk > metrics > Interest Coverage
-69.19586507072906
Risk > final Score
-271
Risk > verdict
High
Liquidity > metrics > Current Ratio
7.413595740319033
Liquidity > metrics > Quick Ratio
7.413595740319033
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
90
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
8
Prev Profitabilities > 2
0
Prev Risks > 0
-289
Prev Risks > 1
-40
Prev Risks > 2
-257
Prev Liquidities > 0
79
Prev Liquidities > 1
80
Prev Liquidities > 2
82
Updated At
2025-12-10T23:29:06.465Z
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$1.0083
Analyst Picks
Strong Buy
4
Buy
0
Hold
14
Sell
2
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 87.38% of the total shares of agilon health Inc
1.
Clayton Dubilier & Rice LLC(24.1299%)
since
2025/06/30
2.
Morgan Stanley - Brokerage Accounts(13.8097%)
since
2025/06/30
3.
Capital World Investors(10.9962%)
since
2025/06/30
4.
FMR Inc(9.4881%)
since
2025/06/30
5.
Vanguard Group Inc(7.3111%)
since
2025/06/30
6.
BlackRock Inc(5.9777%)
since
2025/06/30
7.
Capital Research & Mgmt Co - Division 3(2.3871%)
since
2025/06/30
8.
State Street Corp(1.8583%)
since
2025/06/30
9.
Geode Capital Management, LLC(1.7268%)
since
2025/06/30
10.
Rock Springs Capital Management LP(1.5806%)
since
2025/06/30
11.
Goldman Sachs Group Inc(1.3608%)
since
2025/06/30
12.
Charles Schwab Investment Management Inc(1.1995%)
since
2025/06/30
13.
Wellington Management Company LLP(0.9615%)
since
2025/06/30
14.
Bank of America Corp(0.925%)
since
2025/06/30
15.
Citadel Advisors Llc(0.8944%)
since
2025/06/30
16.
Nuveen, LLC(0.6796%)
since
2025/06/30
17.
Northern Trust Corp(0.6536%)
since
2025/06/30
18.
Algert Global LLC(0.5322%)
since
2025/06/30
19.
CenterBook Partners LP(0.4655%)
since
2025/06/30
20.
Jacobs Levy Equity Management, Inc.(0.4431%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.